The Revolution
IN MIND
With a sharp focus on unique, noninvasive platform technologies, Helius Medical Technologies (Helius) is the medical device holding company working to expand treatment options for patients by amplifying the brain’s ability to heal itself.
Discover HMT
PoNS™ is an investigational device in the US, European Union (EU) and Australia (AUS); PoNS™ is under review for clearance in AUS. PoNS™ is not commercially available in the US, EU or AUS.
Pioneering Portable Neurostimulation
Millions of patients and physicians aim to manage neurological symptoms of disease or trauma, with limited ways to rehabilitate lost function. Helius is studying the PoNS™ device as a new potential treatment option.
Discover HMT
The Revolution in Mind
With a sharp focus on unique, noninvasive platform technologies, Helius Medical Technologies (Helius) is the medical device holding company working to expand treatment options for patients by amplifying the brain’s ability to heal itself.
DISCOVER HMT
Advancing Neurological Treatment Technologies
Through collaboration with distinguished research and production partners, Helius is developing and testing breakthrough technologies as potential treatments for neurological symptoms caused by disease or trauma.
SEE OUR CLINICAL TRIALS
Pioneering Portable Neurostimulation
Millions of patients and physicians aim to manage neurological symptoms of disease or trauma, with limited ways to rehabilitate lost function. Helius is studying the PoNS™ device as a new potential treatment option.
EXPLORE THE PONS DEVICEHelius News
-
Feb 022021
-
Feb 012021
-
Jan 282021
-
Jan 202021
Info For Investors
Helius Medical Technologies is a publicly traded company on the Toronto Stock Exchange under symbol HSM and on the NASDAQ marketplace under symbol HSDT.
Media Resources
Download HMT corporate and product background information, images and logos.
Stock Ticker
Resources
 |
Investor Presentation For a detailed overview please view our Investor Presentation. Open The PPT |